These results suggested a key role for SETd1a relocalization and its associated H3K4me3 activity in creating a more permissive chromatin environment that may promote a mixed lineage cancer stem cell phenotype after loss of MLL1 enzymatic activity. The gene discussed is KMT2A; the disease is cancer.